UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000026391
Receipt No. R000030325
Official scientific title of the study Short-term ulcer healing induced by P-CAB following gastric endoscopic submucosal dissection:a propensity score analysis
Date of disclosure of the study information 2017/03/03
Last modified on 2018/09/11 (Ver. 2)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Short-term ulcer healing induced by P-CAB following gastric endoscopic submucosal dissection:a propensity score analysis
Title of the study (Brief title) Short-term ulcer healing induced by P-CAB following gastric endoscopic submucosal dissection
Region
Japan

Condition
Condition early gastric cancer
Classification by specialty
Gastroenterology
Classification by malignancy Malignancy
Genomic information NO

Objectives
Narrative objectives1 clarify the effect of vonoprazan on promoting ESD-related ulcer healing compared with lansoprazole for 14 days
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes the ulcer reduction ratio 14 days after ESD
Key secondary outcomes

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit
90 years-old >=
Gender Male and Female
Key inclusion criteria the gastric cancers adhering to the expanded criteria
Key exclusion criteria a history of prior surgery,
lesions with scars),
lesions with a steroid injection,
postoperative bleeding,
an additional surgery,
lost to follow-up
Target sample size 100

Research contact person
Name of lead principal investigator Yohei Horikawa
Organization Hiraka General Hospital
Division name Gastroenterology
Address Maego, Yatsukuchi, 3-1, Yokote city
TEL 0182-32-5121
Email horikawa_01@me.com

Public contact
Name of contact person Yohei Horikawa
Organization Hiraka General Hospital
Division name Gastroenterology
Address Maego, Yatsukuchi, 3-1, Yokote city
TEL 0182-32-5121
Homepage URL
Email horikawa_01@me.com

Sponsor
Institute Hiraka General Hospital
Institute
Department

Funding Source
Organization no
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2017 Year 03 Month 03 Day

Progress
Recruitment status Completed
Date of protocol fixation
2017 Year 03 Month 03 Day
Anticipated trial start date
2017 Year 10 Month 01 Day
Last follow-up date
2017 Year 10 Month 01 Day
Date of closure to data entry
2017 Year 10 Month 01 Day
Date trial data considered complete
2017 Year 10 Month 01 Day
Date analysis concluded
2017 Year 10 Month 01 Day

Related information
URL releasing protocol
Publication of results Published
URL releasing results
Results
Other related information nothing

Management information
Registered date
2017 Year 03 Month 03 Day
Last modified on
2018 Year 09 Month 11 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000030325